Atlas Trials

Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass

Clinical trial NCT05487469 · UNKNOWN

Trial details

NCT number
NCT05487469
Sponsor
Nanjing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Rheumatic Heart DiseaseCardiopulmonary BypassImmunotherapy
Start date
2022-07-01
Primary completion
2023-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.